World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
78
Citations
25703
World Ranking
17933
National Ranking
8947

Myron J. Tong publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Myron J. Tong sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 301 publications — 17th percentile

17% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Myron J. Tong D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Myron J. Tong sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 78 D-Index — 12th percentile

12% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Myron J. Tong is affiliated with the University of California, Los Angeles in the United States. Their research primarily focuses on the field of Medicine, with a strong emphasis on Epidemiology and Hepatology. Additional subfields include Molecular Biology, Pathology and Forensic Medicine, and Radiology, Nuclear Medicine and Imaging.

The main topics covered in their work include:

  • Hepatitis B Virus Studies
  • Hepatitis C Virus Research
  • Liver Disease Diagnosis and Treatment
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Hepatitis Viruses Studies and Epidemiology
  • Liver Disease and Transplantation
  • Monoclonal and Polyclonal Antibodies Research

Myron J. Tong has published papers in several venues. Frequent publication outlets are:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Hepatology
  • Clinical Liver Disease
  • Evidence-based Complementary and Alternative Medicine
  • Hepatoma Research

Recent papers include:

  • "Reactivation of Hepatitis B Virus: A Review of Clinical Guidelines" (2020), Clinical Liver Disease
  • "Improved survival after treatments of patients with nonalcoholic fatty liver disease associated hepatocellular carcinoma" (2020), Scientific Reports
  • "Efficacy and Safety of a Botanical Formula Fuzheng Huayu for Hepatic Fibrosis in Patients with CHC: Results of a Phase 2 Clinical Trial" (2022), Evidence-based Complementary and Alternative Medicine
  • "Nonalcoholic fatty liver disease-related hepatocellular carcinoma growth rates and their clinical outcomes" (2021), Hepatoma Research
  • "Cohort study of familial viral hepatitis and risks of paediatric cancers" (2021), International Journal of Epidemiology

The scientist collaborates frequently with a group of co-authors, including:

  • Paul Y. Kwo
  • Ruipeng Lei
  • Lucia A. Rodriguez
  • Nicholas C. Wu
  • Calvin Q. Pan

Best Publications

  • Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B.

    Patrick Marcellin;Ting Tsung Chang;Seng Gee Lim;Myron J. Tong

  • Clinical Outcomes after Transfusion-Associated Hepatitis C

    Myron J. Tong;Neveen S. El-Farra;Andrew R. Reikes;Ruth L. Co

  • 2-Year GLOBE Trial Results: Telbivudine Is Superior to Lamivudine in Patients With Chronic Hepatitis B

    Yun–Fan Liaw;Edward Gane;Nancy Leung;Stefan Zeuzem

  • Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma.

    Howard A. Liebman;Barbara C. Furie;Myron J. Tong;Rita A. Blanchard

  • Sofosbuvir, velpatasvir, and voxilaprevir for previously treated HCV infection

    Marc Bourlière;Stuart C. Gordon;Steven L. Flamm;Curtis L. Cooper

  • A 1-Year Trial of Telbivudine, Lamivudine, and the Combination in Patients With Hepatitis B e Antigen—Positive Chronic Hepatitis B

    Ching-Lung Lai;Nancy Leung;Eng-Kiong Teo;Myron Tong

  • Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in Southern Guangxi, China

    F.-S. Yeh;M.C. Yu;C.-C. Mo;S. Luo

  • Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA.

    John P. Duffy;Andrew Vardanian;Elizabeth Benjamin;Melissa Watson

  • Long‐term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen–positive chronic hepatitis B

    Patrick Marcellin;Ting-Tsung Chang;Seng G Lee Lim;William Sievert

  • Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver.

    David S. K. Lu;Nam C. Yu;Steven S. Raman;Piyaporn Limanond

  • Acetaminophen hepatotoxicity and acute liver failure.

    Linda J. Chun;Myron J. Tong;Ronald W. Busuttil;Jonathan R. Hiatt

  • Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation

    David S. K. Lu;Nam C. Yu;Steven S. Raman;Charles Lassman

  • The long-term outcomes of patients with compensated hepatitis C virus-related cirrhosis and history of parenteral exposure in the United States.

    Ke-Qin Hu;Myron J. Tong

  • Racial differences in responses to therapy with interferon in chronic hepatitis C

    K. Rajender Reddy;Jay H. Hoofnagle;Myron J. Tong;William M. Lee

  • Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology

    J G McHutchison;L M Blatt;M de Medina;J R Craig

  • Yeast-recombinant hepatitis B vaccine. Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission.

    Cladd E. Stevens;Patricia E. Taylor;Myron J. Tong;Pearl T. Toy

  • Recurrence of Hepatocellular Carcinoma Following Liver Transplantation: A Review of Preoperative and Postoperative Prognostic Indicators

    Michael A. Zimmerman;R. Mark Ghobrial;Myron J. Tong;Jonathan R. Hiatt

  • An algorithm for risk assessment and intervention of mother to child transmission of hepatitis B virus.

    Calvin Q. Pan;Zhong–Ping Duan;Kalyan R. Bhamidimarri;Huai–Bin Zou

  • Perinatal hepatitis B virus transmission in the United States. Prevention by passive-active immunization

    Cladd E. Stevens;Pearl T. Toy;Myron J. Tong;Patricia E. Taylor

  • Hepatitis-associated antigen and hepatocellular carcinoma in Taiwan.

    Myron J. Tong;Shih-Chien Sun;Berton T. Schaeffer;Nai-Kwei Chang

Frequent Co-Authors

Sammy Saab
Sammy Saab University of California, Los Angeles
Ronald W. Busuttil
Ronald W. Busuttil University of California, Los Angeles
Girish N. Vyas
Girish N. Vyas University of California, San Francisco
Douglas G. Farmer
Douglas G. Farmer University of California, Los Angeles
Shou-Dong Lee
Shou-Dong Lee Taipei Veterans General Hospital
Seng Gee Lim
Seng Gee Lim National University of Singapore
Jonathan R. Hiatt
Jonathan R. Hiatt University of California, Los Angeles
Robert G. Gish
Robert G. Gish University of Nevada Reno
Kris V. Kowdley
Kris V. Kowdley Washington State University
James W. Mosley
James W. Mosley University of Southern California

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative online pathways can help you build a rewarding career in health and medicine. Nursing professionals may consider an rn to np bridge program to progress from registered nurse to nurse practitioner. This bridge allows for advanced clinical roles and greater autonomy, often with flexible study options.

For those interested in promoting wellness and healthy living, pursuing a nutritionist online degree can open doors to careers in dietetics, health education, and public health policy. These programs often combine foundational science with practical application, preparing graduates for versatile roles.

Students with a passion for healthcare administration should check out cahme accredited mha online programs. Accredited degrees ensure industry standards are met and support roles in hospital management, policy, and more.

Lastly, busy nurses seeking advancement may benefit from rn to bsn programs with no clinicals. These online degrees help RNs gain deeper knowledge and credentials without the need for additional clinical placements.

Best Scientists Citing Myron J. Tong

Trending Scientists

Recently Published Articles